Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Chou

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Molecular Cancer Therapeutics|April 17, 2008
Small molecules targeting histone H4 as potential therapeutics for chronic myelogenous leukemiaC James Chou, Michelle E Farkas, Sherry M Tsai, et al.
Journal of Medicinal Chemistry|May 23, 2018
Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis SimultaneouslyJie Zang, Xuewu Liang, Yongxue Huang, et al.
Bioorganic Chemistry|September 2, 2021
Development of selective HDAC6 inhibitors with in vitro and in vivo anti-multiple myeloma activityShunda Li, Chunlong Zhao, Guozhen Zhang, et al.
Chemistry & Biology|September 26, 2009
Chemical probes identify a role for histone deacetylase 3 in Friedreich's ataxia gene silencingChunping Xu, Elisabetta Soragni, C James Chou, et al.
Comprehensive Psychiatry|February 22, 2005
Predictors of aggression on the psychiatric inpatient serviceMark R Serper, Brett R Goldberg, Kristine G Herman, et al.
Chemmedchem|November 15, 2013
Histone deacetylase inhibitors with enhanced enzymatic inhibition effects and potent in vitro and in vivo antitumor activitiesLei Zhang, Yingjie Zhang, C James Chou, et al.
Journal of the American Society of Nephrology : JASN|December 1, 2010
Inhibition of prolyl hydroxylases increases erythropoietin production in ESRDWanja M Bernhardt, Michael S Wiesener, Paul Scigalla, et al.
Investigative Ophthalmology & Visual Science|May 23, 2013
Inhibition of HDAC2 protects the retina from ischemic injuryJie Fan, Oday Alsarraf, Mohammad Dahrouj, et al.
Frontiers in Pharmacology|September 24, 2019
Discovery of <i>N</i>-(2-Aminophenyl)-4-(bis(2-chloroethyl)amino)Benzamide as a Potent Histone Deacetylase InhibitorLihui Zhang, Xiaoyang Li, Yiming Chen, et al.
Bioorganic & Medicinal Chemistry|May 18, 2017
Design, synthesis and anti-tumor activity study of novel histone deacetylase inhibitors containing isatin-based caps and o-phenylenediamine-based zinc binding groupsShuai Gao, Jie Zang, Qianwen Gao, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Molecular Cancer Therapeutics|April 17, 2008
Small molecules targeting histone H4 as potential therapeutics for chronic myelogenous leukemiaC James Chou, Michelle E Farkas, Sherry M Tsai, et al.
Journal of Medicinal Chemistry|May 23, 2018
Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis SimultaneouslyJie Zang, Xuewu Liang, Yongxue Huang, et al.
Bioorganic Chemistry|September 2, 2021
Development of selective HDAC6 inhibitors with in vitro and in vivo anti-multiple myeloma activityShunda Li, Chunlong Zhao, Guozhen Zhang, et al.
Chemistry & Biology|September 26, 2009
Chemical probes identify a role for histone deacetylase 3 in Friedreich's ataxia gene silencingChunping Xu, Elisabetta Soragni, C James Chou, et al.
Comprehensive Psychiatry|February 22, 2005
Predictors of aggression on the psychiatric inpatient serviceMark R Serper, Brett R Goldberg, Kristine G Herman, et al.
Chemmedchem|November 15, 2013
Histone deacetylase inhibitors with enhanced enzymatic inhibition effects and potent in vitro and in vivo antitumor activitiesLei Zhang, Yingjie Zhang, C James Chou, et al.
Journal of the American Society of Nephrology : JASN|December 1, 2010
Inhibition of prolyl hydroxylases increases erythropoietin production in ESRDWanja M Bernhardt, Michael S Wiesener, Paul Scigalla, et al.
Investigative Ophthalmology & Visual Science|May 23, 2013
Inhibition of HDAC2 protects the retina from ischemic injuryJie Fan, Oday Alsarraf, Mohammad Dahrouj, et al.
Frontiers in Pharmacology|September 24, 2019
Discovery of <i>N</i>-(2-Aminophenyl)-4-(bis(2-chloroethyl)amino)Benzamide as a Potent Histone Deacetylase InhibitorLihui Zhang, Xiaoyang Li, Yiming Chen, et al.
Bioorganic & Medicinal Chemistry|May 18, 2017
Design, synthesis and anti-tumor activity study of novel histone deacetylase inhibitors containing isatin-based caps and o-phenylenediamine-based zinc binding groupsShuai Gao, Jie Zang, Qianwen Gao, et al.
Pageof 10